A Longitudinal Prospective Study Evaluating the Effects of Eltrombopag Treatment On Bone Marrow in Patients with Chronic Immune Thrombocytopenia: Interim Analysis At 1 Year

被引：5
|
作者：
Brynes, Russell K. [1 ]
Orazi, Attilio [2 ]
Wong, Raymond S. M. [3 ]
Bakshi, Kalpana [4 ]
Bailey, Christine K. [4 ]
Brainsky, Andres [4 ]
机构：
[1] USC Keck Sch Med, Dept Pathol, Los Angeles, CA USA
[2] Weill Cornell Med Coll, Dept Pathol & Lab Med, New York, NY USA
[3] Prince Wales Hosp, Dept Med & Therapeut, Hong Kong, Hong Kong, Peoples R China
[4] GlaxoSmithKline, Collegeville, PA USA
来源：
BLOOD | 2012年 / 120卷 / 21期
关键词：
D O I：
10.1182/blood.V120.21.2195.2195
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
2195
引用
收藏
页数：2
相关论文
共 50 条
  • [31] CHARACTERIZATION OF PATIENTS WITH IMMUNE THROMBOCYTOPENIA ENTERING REMISSION IN A ROMIPLOSTIM BONE MARROW STUDY
    Janssens, A.
    Cervinek, L.
    Tejeda Romero, M.
    Wang, X.
    Eisen, M.
    HAEMATOLOGICA, 2016, 101 : 9 - 9
  • [32] Multicentre, randomised phase III study of the efficacy and safety of eltrombopag in Chinese patients with chronic immune thrombocytopenia
    Yang, Renchi
    Li, Junmin
    Jin, Jie
    Huang, Meijuan
    Yu, Ziqiang
    Xu, Xiaojun
    Zhang, Xiaohui
    Hou, Ming
    BRITISH JOURNAL OF HAEMATOLOGY, 2017, 176 (01) : 101 - 110
  • [33] Eltrombopag (EPAG) Treatment Improved Platelet Counts in Patients with Persistent or Chronic Immune Thrombocytopenia during a 2-Year, Phase IV, Open-Label Study
    Wong, Raymond S. M.
    Brynes, Russell K.
    Orazi, Attilio
    Aziz, Zeba
    Melikyan, Anait L.
    Salama, Abdulgabar
    Arikan, Ozlem Ocak
    Maier, Joan
    Shamsi, Tahir
    BLOOD, 2017, 130
  • [34] US Food and Drug Administration approval summary: Eltrombopag for the treatment of pediatric patients with chronic immune (idiopathic) thrombocytopenia
    Ehrlich, Lori A.
    Kwitkowski, Virginia E.
    Reaman, Gregory
    Ko, Chia-Wen
    Nie, Lei
    Pazdur, Richard
    Farrell, Ann T.
    PEDIATRIC BLOOD & CANCER, 2017, 64 (12)
  • [35] Eltrombopag for the treatment of children with persistent and chronic immune thrombocytopenia (PETIT): a randomised, multicentre, placebo-controlled study
    Bussel, James B.
    de Miguel, Purificacion Garcia
    Despotovic, Jenny M.
    Grainger, John D.
    Sevilla, Julian
    Blanchette, Victor S.
    Krishnamurti, Lakshmanan
    Connor, Philip
    David, Michele
    Boayue, Koh B.
    Matthews, Dana C.
    Lambert, Michele P.
    Marcello, Lisa M.
    Iyengar, Malini
    Chan, Geoffrey W.
    Chagin, Karen D.
    Theodore, Dickens
    Bailey, Christine K.
    Bakshi, Kalpana K.
    LANCET HAEMATOLOGY, 2015, 2 (08): : E315 - E325
  • [36] The defective bone marrow-derived mesenchymal stem cells in patients with chronic immune thrombocytopenia
    Zhang, Donglei
    Li, Huiyuan
    Ma, Li
    Zhang, Xian
    Xue, Feng
    Zhou, Zeping
    Chi, Ying
    Liu, Xiaofan
    Huang, Yueting
    Yang, Yanhui
    Yang, Renchi
    AUTOIMMUNITY, 2014, 47 (08) : 519 - 529
  • [37] THROMBOEMBOLIC EVENT MANAGEMENT AND OUTCOMES IN PATIENTS WITH CHRONIC IMMUNE THROMBOCYTOPENIA (CITP) DURING TREATMENT WITH ELTROMBOPAG (EPAG): RESULTS FROM THE EXTEND STUDY
    Saleh, M. N.
    Bussel, J. B.
    Wong, R. S.
    Meddeb, B.
    Salama, A.
    Ocak, O.
    Atkinson, S.
    Quebe-Fehling, E.
    Khelif, A.
    HAEMATOLOGICA, 2017, 102 : 292 - 292
  • [38] ELTROMBOPAG (EPAG) FOR THE TREATMENT OF PATIENTS AGED ≥65 YEARS WITH CHRONIC IMMUNE THROMBOCYTOPENIA (CITP): SAFETY AND EFFICACY RESULTS FROM THE EXTEND STUDY
    Salama, A.
    Wong, R. S.
    Khelif, A.
    Saleh, M. N.
    Meddeb, B.
    Arikan, O. Ocak
    Quebe-Fehling, E.
    Bussel, J. B.
    HAEMATOLOGICA, 2017, 102 : 587 - 588
  • [39] Treatment of immune thrombocytopenia (ITP) with eltrombopag - results of the 5th interim analysis of the German non-interventional trial RISA
    Meyer, Oliver
    Schlag, Rudolf
    Stauch, Thomas
    Fleischmann, Bastian
    Reiser, Marcel
    Kaempfe, Dietrich
    Behlendorf, Timo
    Welslau, Manfred
    von der Heyde, Eyck
    Doerfel, Steffen
    Willy, Claudia
    Stauch, Martina
    ONCOLOGY RESEARCH AND TREATMENT, 2022, 45 (SUPPL 3) : 190 - 190
  • [40] Treatment of Immune Thrombocytopenia (ITP) with Eltrombopag - Results of the 3rd Interim Analysis of the German Non-Interventional Trial RISA
    Meyer, Oliver
    Stauch, Martina
    Kaempfe, Dietrich
    Schlag, Rudolf
    Reiser, Marcel
    von der Heyde, Eyck
    Josting, Andreas
    Plath, Margarete
    Ballerstadt, Nadine
    Stark-Lorenzen, Petra
    Matzdorff, Axel
    BLOOD, 2020, 136
12345